Status:
COMPLETED
Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs
Lead Sponsor:
University of Connecticut
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
APT Foundation, Inc.
Conditions:
Risk Behavior
HIV/AIDS
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will evaluate the efficacy and cost-effectiveness of CHRP-BB - an integrated bio-behavioral approach that incorporates the use of PrEP - with an evidence-based behavioral approach aimed at ...
Detailed Description
PWUD remain a priority population as they represent a critical conduit for new HIV infections, which are transmitted through preventable drug- and sex-related HIV risk behaviors. Pre-Exposure Prophyla...
Eligibility Criteria
Inclusion
- Meet DSM-V criteria for opioid-dependence and are enrolled in methadone maintenance drug treatment at the APT Foundation, Inc.
- Were confirmed to be HIV-negative and started on PrEP in the past week
- Report unsafe injection drug use practices or unprotected sex within the past 3 months
- Have a cell phone
- Are able to read and understand the questionnaires, ACASI, and informed consent form
- Available for the full duration of the study with no anticipated circumstances impeding participation (e.g., pending charges, jail term).
Exclusion
- Have an untreated bipolar or psychotic disorder
- Are actively suicidal or homicidal as assessed by trained research staff under the supervision of a licensed clinical psychologist
- Cannot speak English
Key Trial Info
Start Date :
November 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 13 2023
Estimated Enrollment :
237 Patients enrolled
Trial Details
Trial ID
NCT03282890
Start Date
November 20 2017
End Date
October 13 2023
Last Update
August 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
APT Foundation
New Haven, Connecticut, United States, 06511